US Patent Issued to BAYER, BAYER PHARMA on March 25 for "Method for preparing 2-[(3R)-3-methylmorpholin-4-yl-4-[1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine" (Dutch, German Inventors)

Posted On: 2025-03-26

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,343, issued on March 25, was assigned to BAYER AG (Leverkusen, Germany) and BAYER PHARMA AG (Berlin).

"Method for preparing 2-[(3R)-3-methylmorpholin-4-yl-4-[1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine" was invented by Johannes Platzek (Berlin), Philipp Rubenbauer (Bensheim, Germany), Hendricus Nicolaas Sebastiaan Van Der Haas (Nijmegen, Netherlands), Sonja Elisabeth Hoogeveen (Oss, Netherlands), Matthijs Cornelis Maria Van Oers (Nijmegen, Netherlands), Reinerus Gerardus Gieling (Beuningen, Netherlands) and Jeroen Alexander Dekker (Ede, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention covers a met...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to BAYER, BAYER PHARMA on March 25 for "Method for preparing 2-[(3R)-3-methylmorpholin-4-yl-4-[1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine" (Dutch, German Inventors)